You just read:

Additional Interim Data Supporting Long-Term Use of Vedolizumab in Patients with Ulcerative Colitis and Crohn's Disease Published in Journal of Crohn's and Colitis

News provided by

Takeda Pharmaceutical Company Limited

Sep 28, 2016, 15:16 ET